These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32103675)

  • 1. Chemokines-What Is Their Role in Colorectal Cancer?
    Pączek S; Łukaszewicz-Zając M; Mroczko B
    Cancer Control; 2020; 27(1):1073274820903384. PubMed ID: 32103675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis.
    Itatani Y; Kawada K; Inamoto S; Yamamoto T; Ogawa R; Taketo MM; Sakai Y
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact.
    Braoudaki M; Ahmad MS; Mustafov D; Seriah S; Siddiqui MN; Siddiqui SS
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):436-449. PubMed ID: 35700938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional roles of chemokines and chemokine receptors in colorectal cancer progression.
    Yue M; Chen MM; Zhang B; Wang Y; Li P; Zhao Y
    Biomed Pharmacother; 2024 Jan; 170():116040. PubMed ID: 38113624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Significance of CXCL1 and CXCL8 as Well as Their Specific Receptors in Colorectal Cancer.
    Łukaszewicz-Zając M; Pączek S; Mroczko P; Kulczyńska-Przybik A
    Cancer Manag Res; 2020; 12():8435-8443. PubMed ID: 32982437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
    Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
    Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
    De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
    Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary nodules and metastases in colorectal cancer.
    Nordholm-Carstensen A
    Dan Med J; 2016 Jan; 63(1):B5190. PubMed ID: 26726908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics, diagnosis and management of colorectal cancer (Review).
    De Rosa M; Pace U; Rega D; Costabile V; Duraturo F; Izzo P; Delrio P
    Oncol Rep; 2015 Sep; 34(3):1087-96. PubMed ID: 26151224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic determinants of ovarian metastases from colorectal cancer.
    Ganesh K; Shah RH; Vakiani E; Nash GM; Skottowe HP; Yaeger R; Cercek A; Lincoln A; Tran C; Segal NH; Reidy DL; Varghese A; Epstein AS; Sonoda Y; Chi D; Guillem J; Temple L; Paty P; Hechtman J; Shia J; Weiser M; Aguilar JG; Kemeny N; Berger MF; Saltz L; Stadler ZK
    Cancer; 2017 Apr; 123(7):1134-1143. PubMed ID: 27875625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular features of young-onset colorectal cancer.
    Ballester V; Rashtak S; Boardman L
    World J Gastroenterol; 2016 Feb; 22(5):1736-44. PubMed ID: 26855533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
    Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
    Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel chemokine signaling-based multigene signature to predict prognosis and therapeutic response in colorectal cancer.
    Qi X; Yan D; Zuo J; Wang R; Chen J
    J Zhejiang Univ Sci B; 2021 Dec; 22(12):1053-1059. PubMed ID: 34904417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Chemokines in the Development of Gastric Cancer - Diagnostic and Therapeutic Implications.
    Pawluczuk E; Łukaszewicz-Zając M; Mroczko B
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs in colorectal cancer.
    Xie X; Tang B; Xiao YF; Xie R; Li BS; Dong H; Zhou JY; Yang SM
    Oncotarget; 2016 Feb; 7(5):5226-39. PubMed ID: 26637808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.